Study on Long-Term Safety of Secukinumab for Patients with Polymyalgia Rheumatica
- Substances:Secukinumab
Hungary- Participants:18–64 years · 65+ years
- Substances:Secukinumab
- Sponsor:Novartis Pharma AG
Rare diseases
Investigational molecules
Locations
Back to Hungary339 clinical trials in Szeged, Hungary across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
Hungary
HungaryThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on glioblastoma multiforme and immune system responses, alongside innovative treatments for bladder cancer and colorectal cancer. Research includes evaluating new therapeutic combinations and investigating treatment efficacy in various cancer types.
Comprehensive research addressing heart failure prevention and hypertrophic cardiomyopathy. Clinical trials are evaluating new drug combinations and investigating innovative approaches to improve cardiovascular outcomes.
Studies targeting psoriatic arthritis, ulcerative colitis, and chronic rhinosinusitis. Research focuses on evaluating new biological treatments and investigating novel therapeutic approaches for inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.